Wegovy vs Mounjaro: Which Weight Management Option Suits You?
Wegovy Mounjaro: Understanding the Key Mechanism Differences
When comparing Wegovy vs Mounjaro, the fundamental difference lies in their active ingredients and how they work in your body. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural fullness hormone, helping to reduce appetite and promote satiety after smaller meals. Mounjaro utilises tirzepatide, which targets both GIP and GLP-1 receptors, offering a dual mechanism approach to weight management alongside blood sugar regulation.
Both prescription-only medicines require weekly injections and must be prescribed alongside lifestyle modifications including a reduced-calorie diet and increased physical activity. The choice between Wegovy and Mounjaro often depends on individual factors such as medical history, other medications, and how your body responds to treatment. Your prescriber can evaluate these factors during the clinical assessment process to recommend the most suitable option for your weight management journey.
Wegovy Mounjaro Pricing: Transparent Costs for Both Options
EverydayMeds offers competitive pricing for both Wegovy and Mounjaro, with clear cost structures and discount codes to help manage your investment in weight management. Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. New customers can apply code FIRST40 at checkout, while returning customers use DOSE25 to access these final prices.
Our bundle options provide convenience for those planning ahead, such as the Intro Duo (0.25mg & 0.5mg) for £169.99 or the Ultimate Stability Trio (three 2.4mg pens) for £649.99. Mounjaro pricing follows a different structure due to its unique dosing schedule, with six strength options ranging from 2.5mg to 15mg. Both medications require dose escalation over several months, making it important to factor in the total treatment cost when comparing Wegovy vs Mounjaro options.
Clinical Evidence: Wegovy Mounjaro Research Foundations
The clinical evidence supporting both Wegovy and Mounjaro comes from extensive research programmes, though direct head-to-head comparisons are limited due to different trial designs and populations. Wegovy's efficacy was established through the STEP trial programme, with STEP 1 showing patients achieved approximately 15% average weight loss at 68 weeks when taking semaglutide alongside diet and exercise, compared to 2.4% with placebo (Wilding et al., NEJM, 2021).
Mounjaro's clinical foundation stems from the SURMOUNT trials, demonstrating the effectiveness of tirzepatide's dual mechanism approach. Both medications have undergone rigorous MHRA evaluation and carry the black triangle symbol (▼) indicating additional monitoring as newer treatments. Your prescriber will consider this evidence alongside your individual circumstances when discussing whether Wegovy or Mounjaro may be more suitable for your weight management goals.
How Wegovy Works: GLP-1 Mechanism for Appetite Control
Wegovy's semaglutide works by mimicking GLP-1, a natural hormone your body produces after eating that signals fullness to your brain. This mechanism helps reduce appetite and may decrease food cravings by working on the brain's appetite centres. When you inject Wegovy once weekly using the FlexTouch pen, the medication helps you feel satisfied with smaller portions and may reduce the urge to snack between meals. The treatment works best when combined with dietary changes and increased physical activity, as the medication supports but doesn't replace healthy lifestyle choices. Understanding this mechanism helps explain why Wegovy requires gradual dose escalation over 16 weeks, allowing your body to adjust to the medication's appetite-suppressing effects progressively.
Ordering Process: Simple Steps for Wegovy Mounjaro Access
EverydayMeds has streamlined the process for accessing both Wegovy and Mounjaro through our GPhC-registered online pharmacy service. The journey begins with a comprehensive 3-minute clinical assessment covering your medical history, current medications, weight management goals, and suitability for either treatment option. Your responses are reviewed by qualified prescribers who can recommend whether Wegovy or Mounjaro aligns better with your individual needs and circumstances. Standard prescriber review takes three working days, with express 24-hour options available for urgent requirements. Once approved, your medication is dispatched via next-day delivery using temperature-controlled cold-chain logistics to maintain product integrity from our pharmacy to your door.
Storage Differences: Wegovy Mounjaro Practical Considerations
One practical advantage when comparing Wegovy vs Mounjaro lies in storage flexibility, particularly important for frequent travellers or those with busy lifestyles. Wegovy can remain at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, while Mounjaro maintains stability for 21 days under similar conditions. Both medications require refrigeration at 2-8°C before first use and come in pre-filled FlexTouch pens designed for single use. The dose escalation schedule differs between treatments: Wegovy follows a 5-step progression over 16 weeks, while Mounjaro typically uses 6 dose levels over a longer titration period. Proper storage and adherence to the prescribed escalation schedule are crucial for both medications' effectiveness and safety profile.
Wegovy Mounjaro: Dual Pathway Benefits and Individual Responses
The choice between Wegovy's single GLP-1 mechanism and Mounjaro's dual GIP/GLP-1 approach often comes down to individual response patterns and clinical considerations. Some patients may respond better to semaglutide's focused GLP-1 action, while others benefit from tirzepatide's broader hormonal influence on both appetite and glucose metabolism. Both treatments require long-term commitment, as clinical trials show patients typically regain weight when discontinuing medication.
Your prescriber will consider factors such as diabetes status, cardiovascular risk, previous medication responses, and personal preferences when recommending between these options. EverydayMeds' comprehensive clinical assessment captures these nuances, ensuring you receive personalised guidance rather than a one-size-fits-all approach to weight management medication selection.
Choose Your Wegovy Mounjaro Option: Expert Guidance Available
Both Wegovy and Mounjaro represent significant advances in prescription weight management, each offering unique benefits depending on your individual circumstances and treatment goals. EverydayMeds provides access to both options through our regulated UK pharmacy service, with expert prescriber guidance to help navigate this important healthcare decision. Whether you're drawn to Wegovy's established semaglutide profile or interested in exploring Mounjaro's innovative dual mechanism, our clinical team can provide the personalised assessment needed for informed treatment selection. New customers can use code FIRST40 at checkout, while returning customers apply DOSE25 to access competitive pricing on both medications. Visit our weight loss collection at https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and discover which option aligns best with your weight management journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
